Publications

Charles M Bliss Jr

  • Charles M. Bliss, Jr. Endoscopic diagnosis and management of hereditary nonpolyposis colon cancer. Current Opinion in Gastroenterology. 20: 468-473, 2004.

Albena Halpert

  • Halpert A, Drossman D. Biopsychosocial issues in irritable bowel syndrome. J ournal of Clinical Gastroenterology. 39(8):665-9, 2005.
  • Halpert A, Dalton CB, Diamant NE, Toner BB, Hu Y, Morris CB, Bangdiwala SI, Whitehead WE, Drossman DA. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage. American Journal of Gastroenterology. 100(3):664-71, 2005.

Francis A Farraye

  • Emmons, K: McBride, CM: Puleo, E: Pollak, KI: Clipp, E: Kuntz, K: Marcus, BH: Napolitano, M:Onkem, J: Farraye, F: Fletcher, R. Project PREVENT: A randomized trial to reduce multiple behavioral risk factors for colon cancer. Cancer Eoidemiol Biomarkers Prev. 14:(6): 1453-9, 2005.
  • Huang, C: Lal, S: Farraye, FA. Colorectal Cancer Screening. Cancer Causes Control. 16: 171-88, 2005.
  • Majumdar, SR: Soumerai, SB: Farraye, FA: Lee, M: Kemp, A: Henning, LM: Schrammel, MPA: Lecates, R: Ross-Degnon, D. Controlled Trial of Interventions to Increase Testing and Treatment for Helicobacter pylori and Reduce Medication Use in Patients with Chronic Acid-Related Symptoms. Aliment Pharmacol Ther. 21: 1029-39, 2005.
  • Levin,TR: Farraye, FA: Schoen, RE: Hoeff, G: Atkin, W: Bond, JH: Winawer, S: Burt, RW: et.al. Quality in the technical performance of screening flexible sigmoidoscopy. Recommendations of an international multisociety task force on colorectal cancer. Gut. 54: 807-813, 2005.
  • Ahn, L: Andrews, C: Forse, A: Hess, D: Farraye, FA. Crohn’s Disease after Gastric Bypass Surgery for Morbid Obesity: Is there an Association? . IBD Journal. 11: 622-4, 2005.
  • Schroy, PC: Lal, SK: Wilson, S: Heeren, T: Farraye, FA. Deficiencies in Knowledge and Familial Risk Communication Among Colorectal Adenoma Patients. J Clin GASTROENTEROL. 39: 298-302, 2005.
  • Emmons, KM: Mc Bride, CM: Puleo, E: Pollak, K: Marcus, BH: Nalolitano, M:, Clipp, E: Onken, J: Farraye, FA: Fletcher, R. Prevalence and Predictors of Multiple Behavioral Risk Factors for Colon Cancer. Prev Med. 40: 527-34, 2005.
  • Huang, C: Farraye, FA. Endoscopy in the Bariatric surgery patient. Gastroenterol Clinics North America . 34: 151-66, 2005.
  • Yang, S: Farraye, FA: Mack, C: Posnik, O: O’Brien, MJ. BRAF and KRAS Mutations in Hyperplastic Polyps and Serrated Adenomas of the Colorectum: Relationship to Histology and CpG Island Methylation Status. Amer J Surg Path. 28: 1452-9, 2004.
  • Odze, RD: Farraye, FA: Hecht, JL: Hornick, JL. Long term follow-up confirms that polypectomy is adequate treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2: 534-41, 2004.
  • Yantiss, RK: Sapp, H: Farraye, FA: EL-Zimmer, O: Obrien, MJ: Becker, JM: Fruin, AB: Odze, RD. Histologic Predictors of the Development of Chronic Pouchitis in Patients with Ulcerative Colitis. Amer J Surg Path. 28: 999-1006, 2004.
  • Glickman, J: Bousvaros, A: Farraye, FA: Zholudev, A: Friedman, S: Wang, HH: Leichter, A: Odze, RD. Pediatric Patients with Untreated Ulcerative Colitis May Present Initially with Unusual Morphologic Findings. Journal of Surgical Pathology. 28: 190-7, 2004.
  • Farraye, FA: Wong, M: Hurwitz, S: Puleo, E: Emmons, KM: Wallace, M: Fletcher R. Barriers to endoscopic colorectal cancer screening: Are women different than men? . Am J Gastro. 99: 341-349, 2004.
  • Huang, C: OBrien, MJ: Yang, S: Farraye FA. Hyperplastic polyps, serrated adenomas and the serrated polyp neoplasia pathway. Am J Gastroenterol. 99: 2242-55, 2004.
  • Sangha, S: Soto, J: Becker, JM: Farraye FA. Primary epiploic appendagitis: An underappreciated diagnosis. Dig Dis Sci. 49: 347-50, 2004.
  • Shaz, BH: Reddy, SI: Ayata, G: Brien, T: Farraye, FA: Antoniolo, DA: Odze, RD: Wang, HH. Sequential clinical and histopathologic changes in collagenous and lymphocytic colitis over time. Modern Pathology . 17: 395-401, 2004.
  • O’Brien, MJ: Yang, S: Clebanoff, JL: Mulcahy, E: Farraye, FA: Amorosino, M: Swan N. CpG Island methylator phenotype and K-ras mutations in sporadic hyperplastic polyps of the proximal and distal colorectum. Amer J Surg Path . 28: 423-34, 2004.

David P Nunes

  • Nunes D, Schroy PC. Another step forward: Treating HCV infection in HIV coinfected patients. Gastroenterology. 128:(2): 513-5, 2005.
  • Fleming C, Tumilty S, Murray JE, Nunes D. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus need for team care. Clin Infect Dis. 40 :(Suppl 5): S349-54, 2005.
  • Graham CS, Curry M, He O, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ. Comparison of HCV-specific intrahepatic CD4+ Tcells in HIV/HCV versus HCV. Hepatology. 40:(1): 125-132, 2004.

Gwynneth D Offner

  • Li, X., Wang, L., Nunes, D.P., Troxler, R.F. and Offner, G.D. Suppression of MUC1 Synthesis Downregulates Expression of the Epidermal Growth Factor Receptor . Cancer Biology and Therapy. in press:2005.

Paul C Schroy Iii

  • Lowe R, Schroy PC. Early HVPG measurement and tips for acute variceal hemorrhage: is sooner really better? [Selected Summary] . Gastroenterology . 128: 1136-9, 2005.
  • Nunes D, Schroy PC. Another step forward: Treating HCV infection in HIV coinfected patients. [Selected Summary]. Gastroenterology. 128: 513-5, 2005.
  • Schroy PC, Geller A, Jackson A, Glick J, Prout M. A Novel Educational Strategy to Enhance Internal Medicine Residents’ Familial Colorectal Cancer Knowledge and Risk Assessment Skills. Am J Gastro. 100: 677-84, 2005.
  • Schroy P, Heeren T. Patient perceptions and screening preferences: a comparative study of stool-based DNA testing, fecal occult blood testing and colonoscopy . Am J Prev Med. 28:208-14: 208-12, 2005.
  • Schroy PC, Lal S, Wilson S, Heeren T, Farraye F. Deficiencies in knowledge and familial risk communication among colorectal adenoma patients. J Clin Gastro. 39: 298-302, 2005.
  • Bliss CM, Schroy PC. Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol. 20: 468-73, 2004.
  • Farraye FA, Schroy PC. Tailoring use of screening colonoscopy – are we up to the challenge? [Selected Summary]. Gastroenterology. 127: 673-5, 2004.
  • Ferrucci J, Schroy PC. Virtual colonoscopy: good results and not so got results – why the difference? [Selected Summary]. Gastroenterology. 127: 1633-6, 2004.
  • Bliss CM, Schroy PC. Primary intestinal lymphangiectasia. Current Treatment Options in Gastroenterology . 7: 3-6, 2004.

Horst C Weber

  • Chinnappan, D., Xiao, D. and H.C.Weber. Transcriptional Activation of the Human GRP-receptor in Colon Cancer Cells. Gastroenterology . 128:(4): A140, 2005.
  • Michael Chang, David Nunes, Francis F. Farraye, and Horst C. Weber. Successful management of bleeding colonic varices by variceal band ligation. Am. J. Gastroenterology . 99:(10): S155, 2004.
  • H.C.Weber, Albanese, C., Pestell, R., and Xiao, D. Bombesin Regulates Cyclin D1 Expression Through EGR-1 Dependent Mechanisms. Regulatory Peptides . 122:(1): 47, 2004.
  • H.C.Weber, Xiao, D., Garla, S., Qu, X., Coy, D., and Qin, X. A Novel Selective BRS-3 Agonist Mediates CREB Phosphorylation and Transactivation. Regulatory Peptides . 122:(1): 47, 2004.

M Michael Wolfe

  • Sangha S, Yao M, Wolfe MM. Nonsteroidal anti-inflammatory drugs and colorectal cancer prevention. Postgrad Med J . 81: 223-227, 2005.
  • Chang AJ, Song DH, Wolfe MM. Gastrin stimulation of colorectal cancer cell proliferation is mediated in part by activation of ERK1/2 and transactivation of the EGF receptor leading to the proteasomal degradation of PPAR gamma. Gastroenterology. 128: A-42, 2005.
  • Song DH, Kaufman JC, Borodyansky L, Albanese C, Pestell RG, Wolfe MM. Gastrin stabilises beta-catenin protein in mouse colorectal cancer cells. British Journal of Cancer. 25: 1581-1587, 2005.
  • Song DH, Getty-Kaushik L, Tseng E, Simon J, Corkey BE, Wolfe MM. The role of glucose-dependent insulinotropic polypeptide (GIP) in adipocyte development and signaling. Gastroenterology. 128: A-9, 2005.
  • Jepeal LI, Fujitani Y, Boylan MO, Wilson CN, Wright CV, Wolfe MM. Cell-specific expression of glucose-dependent insulinotropic polypeptide (GIP) requires the transcription factor PDX-1. Endocrinology. 146: 383-391, 2005.
  • Schaefer KL, Wada K, Takahashi H, Matsuhashi N, Ohnishi S, Wolfe MM, Turner JR, Nakajima A, Borkan SC, Saubermann LJ. Proliferator-activated receptor gamma inhibition prevents adhesion of the extracellular matric and induces anoikis in hepatocellular carcinoma cells. Cancer Research. 65: 2251-2259, 2005.
  • Yao M, Zhou W, Sangha S, Albert A, Chang AJ, Wolfe MM. Non-selective COX inhibition with ibuprofen attenuates tumor growth and liver metastasis, and enhances the antitumor efficacy of chemotherapy in colorectal cancer. Clin Canc Res. 11: 1618-1628, 2005.
  • Jacobson BC, Wolfe MM. Endoscopic and Radiographic procedures in gastroenterology. Cecil Essentials of Medicine, sixth edition. Andreoli TE et al., Eds. Philadelphia: W.B. Saunders Company. 333-339, 2004.
  • Lowe RC, Wolfe MM. Diseases of the esophagus. Cecil Essentials of Medicine, sixth edition. Andreoli TE et al., Eds. Philadelphia: W.B. Saunders Company. 341-349, 2004.
  • Song DH, Bowdish EA, Rana B, Wolfe JR, Wolfe MM. Gastrin and cell growth. Gastrin in the New Millennium, Merchant J et al., Eds. CURE Foundation . 299-310, 2004.
  • Lowe RC, Wolfe MM. The pharmacological management of gastroesophageal reflux disease. Minerva Gastroenterol Dietol . 50: 227-237, 2004.
  • Moore TC, Jepeal LI, Boylan MO, Singh SK, Boyd N, Beer DG, Wolfe MM. Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells. Regulatory Peptides. 120: 195-203, 2004.
  • Bliss CM, Wolfe MM. Abdominal pain. Cecil Essentials of Medicine, sixth edition. Andreoli TE et al., Eds. Philadelphia: W.B. Saunders Company. 313-316, 2004.
  • Tseng C-C, Wolfe MM. Gastrointestinal hemorrhage. Cecil Essentials of Medicine, sixth edition. Andreoli TE et al., Eds. Philadelphia: W.B. Saunders Company. 317-320, 2004.
  • Oviedo JA, Wolfe MM. Diseases of the stomach and duodenum. Cecil Essentials of Medicine, sixth edition. Andreoli TE et al., Eds. Philadelphia: W.B. Saunders Company. 347-362, 2004.
  • McGuigan JE, Belafsky PC, Fromer L, McCarthy D, Nostrant T, Postma GN, Welage LS, Wolfe MM. Review article: diagnosis and management of night-time reflux. Aliment Pharmacol Ther. 20:(Suppl 9): 57-72, 2004.
  • Wolfe MM. Rofecoxib, Merck, and the FDA. N Engl J Med . 30:(351(27)): 2875-2878, 2004.
Publications for Med VA Hospital

Marcos C Pedrosa

  • Jacobson B.C., Shami V.M., Larghi A., Chi K.D., Kahaleh M., Dye C., Pedrosa M., Waxman I.. TTS-Balloon Dilation for EUS Staging of Esophageal Cancer: A Multi-Center Safety Study. Gastrointestinal Endoscopy . 61:(5): A#S1096, 2005.
  • Mashimo H., Desai S., Pedrosa M., Wagh M., Chen Y., Herz P., Hsiung P., Aguirre A., Koski A., Schmitt J., Fujimoto J.G.. Ultrahigh Resolution Endoscopic Optical Coherence Tomography: a Novel Technology for Gastrointestinal Imaging. Gastroenterology. 128:(4): S1763, 2005.
  • Morgan TR , Weiss DG, Nemchausky B, Schiff ER, Anand B, Francis Simon F, Kidao J, Cecil B, Mendenhall CL, Nelson D, Lieber C, Pedrosa M, Jeffers L, Bloor J, Lumeng L, Marsano L, McClain C, Mishra G, Myers B, Leo M, Ponomarenko Y, Taylor D, Chedid A,. Colchicine treatment of alcoholic cirrhosis: A randomized, placebo-controlled clinical trial of patient survival. Gastroenterology . 128:(4): 882-90, 2005.
  • Yee H.S., Currie S.L.,Pedrosa M.C., Anand B.S., Shen H., Bini E.J., Jeffers L.J., Wright T.L., For VA-HCV-001 Study Group. African Americans and Less Educated Patients With Chronic Hepatitis C Are Less Likely To Be Tested for Hepatitis a Immunity and Hepatitis B Infectivity . Gastroenterology. 128:(4): A#48797, 2005.
  • Lal SK, Pedrosa MC, Orlander J, Klein MA. Primary Biliary Cirrhosis in an 86-year-old male. . Digestive Diseases and Science . 48:(8): 1627-9, 2003.
Primary teaching affiliate
of BU School of Medicine